Genomic alterations are associated with response to aromatase inhibitor therapy for ER-positive postmenopausal ductal carcinoma in situ: (CALGB 40903, Alliance)
基因组改变与雌激素受体阳性绝经后导管原位癌对芳香化酶抑制剂治疗的反应相关:(CALGB 40903,Alliance)
期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-025-01963-5
Marks, Jeffrey R; Zhang, Dadong; Hardman, Timothy; Chen, Yunn-Yi; Hall, Allison; Simpson, Lunden; Hieken, Tina; Bedrosian, Isabelle; Price, Elissa; Sheng, Jeff; Dai, Yanwan; Lee, Marissa; Sibley, Alexander B; Owzar, Kouros; Hwang, E Shelley